Rani Therapeutics to Participate in August Investor Conferences
Rani Therapeutics (Nasdaq: RANI), a clinical-stage biotherapeutics company focusing on oral delivery of biologics and drugs, has announced its participation in two upcoming investor conferences in August 2024. The company will attend the BTIG Virtual Biotechnology Conference on August 5th-6th, participating in one-on-one investor meetings. Additionally, Rani will present at the Canaccord 44th Annual Growth Conference in Boston on August 13th at 3:30 PM ET, featuring a company presentation by CEO Talat Imran and investor meetings.
Interested parties can access live webcasts of these events through the 'Events' section of Rani Therapeutics' website. Webcast replays will be available after the presentations conclude.
Rani Therapeutics (Nasdaq: RANI), un'azienda biofarmaceutica in fase clinica che si concentra sulla somministrazione orale di biologici e farmaci, ha annunciato la sua partecipazione a due prossime conferenze per investitori nell'agosto 2024. L'azienda parteciperà al BTIG Virtual Biotechnology Conference il 5-6 agosto, prendendo parte a incontri individuali con gli investitori. Inoltre, Rani presenterà al Canaccord 44th Annual Growth Conference a Boston il 13 agosto alle 15:30 ET, con una presentazione aziendale del CEO Talat Imran e incontri con gli investitori.
Le parti interessate possono accedere alle dirette web di questi eventi nella sezione 'Eventi' del sito web di Rani Therapeutics. Le registrazioni delle trasmissioni saranno disponibili dopo la conclusione delle presentazioni.
Rani Therapeutics (Nasdaq: RANI), una empresa biofarmacéutica en etapa clínica que se enfoca en la administración oral de biológicos y medicamentos, ha anunciado su participación en dos próximas conferencias para inversores en agosto de 2024. La empresa asistirá a la BTIG Virtual Biotechnology Conference del 5 al 6 de agosto, participando en reuniones individuales con inversores. Además, Rani presentará en la Canaccord 44th Annual Growth Conference en Boston el 13 de agosto a las 3:30 PM ET, con una presentación de la compañía por el CEO Talat Imran y reuniones con inversores.
Las partes interesadas pueden acceder a las transmisiones en vivo de estos eventos a través de la sección 'Eventos' del sitio web de Rani Therapeutics. Las repeticiones de las transmisiones estarán disponibles después de que concluyan las presentaciones.
라니 테라퓨틱스 (Nasdaq: RANI)는 생물학 및 약물의 경구 전달에 중점을 둔 임상 단계의 생물 약리학 회사로, 2024년 8월 예정된 두 번의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 8월 5일부터 6일까지 BTIG 가상 생명공학 회의에 참석하며, 일대일 투자자 회의에 참여할 예정입니다. 또한, 라니는 8월 13일 보스턴에서 열리는 캐너코드 제44회 연례 성장 회의에서 오후 3시 30분 ET에 CEO 탈랏 이므란의 회사 발표와 투자자 회의를 진행할 것입니다.
관심 있는 분들은 라니 테라퓨틱스 웹사이트의 '이벤트' 섹션을 통해 이 이벤트의 라이브 웹캐스트에 접속할 수 있습니다. 발표가 끝난 후 웹캐스트 재방송도 제공될 예정입니다.
Rani Therapeutics (Nasdaq: RANI), une entreprise biopharmaceutique en phase clinique axée sur l'administration orale de biologiques et de médicaments, a annoncé sa participation à deux prochaines conférences pour les investisseurs en août 2024. L'entreprise assistera à la BTIG Virtual Biotechnology Conference les 5 et 6 août, participant à des réunions individuelles avec des investisseurs. De plus, Rani présentera lors de la Canaccord 44th Annual Growth Conference à Boston le 13 août à 15h30 ET, avec une présentation de l'entreprise par le PDG Talat Imran et des réunions avec des investisseurs.
Les personnes intéressées peuvent accéder aux webinaires en direct de ces événements via la section 'Événements' du site web de Rani Therapeutics. Des rediffusions des webinaires seront disponibles après la conclusion des présentations.
Rani Therapeutics (Nasdaq: RANI), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die orale Verabreichung von Biologika und Arzneimitteln konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im August 2024 bekannt gegeben. Das Unternehmen wird am BTIG Virtual Biotechnology Conference am 5. und 6. August teilnehmen und an Einzelgesprächen mit Investoren teilnehmen. Darüber hinaus wird Rani am 13. August um 15:30 Uhr ET auf der Canaccord 44th Annual Growth Conference in Boston präsentieren, einschließlich einer Unternehmenspräsentation des CEO Talat Imran und Investorenmeetings.
Interessierte Parteien können die Live-Webcasts dieser Veranstaltungen über den Abschnitt 'Veranstaltungen' der Webseite von Rani Therapeutics abrufen. Die Aufzeichnungen der Webcasts werden nach Abschluss der Präsentationen zur Verfügung stehen.
- None.
- None.
SAN JOSE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in August 2024. These conferences include:
BTIG Virtual Biotechnology Conference
Location: Virtual
Date: Monday, August 5th – Tuesday, August 6th, 2024
Format: 1x1 Investor Meetings
Canaccord 44th Annual Growth Conference
Location: Intercontinental Hotel, Boston, MA
Date: Tuesday, August 13th, 2024 at 3:30pm E.T.
Format: Company Presentation and 1x1 Investor Meetings
Presenter: Chief Executive Officer, Talat Imran
Interested parties can register for and access the live webcasts for these conferences by visiting the “Events” section of the Rani Therapeutics website. The webcast replays will be available after the conclusion of the respective presentations.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology. For more information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
FAQ
What investor conferences will Rani Therapeutics (RANI) attend in August 2024?
When and where will Rani Therapeutics (RANI) present at the Canaccord Growth Conference?
Who will be presenting for Rani Therapeutics (RANI) at the Canaccord Growth Conference?
How can investors access the webcasts of Rani Therapeutics' (RANI) conference presentations?
What type of meetings will Rani Therapeutics (RANI) participate in at the BTIG Virtual Biotechnology Conference?
